https://www.selleckchem.com/pr....oducts/liraglutide.h
Pathogenic variants were identified in 9/33 (27%) women who underwent constitutional testing, aged 33-59 years (median 48 years), including one whose tumour was mismatch repair proficient. Most Lynch syndrome tumours were of endometrioid histological subtype. Tumour mismatch repair deficiency identified by immunohistochemistry is a useful prescreen for constitutional testing in women with ovarian cancer with personal or family histories suggestive of Lynch syndrome. Tumour mismatch repair deficiency identified by immunohistochemistr
Curtir
Comentario
Compartilhar
